Investment Objective: Precidian ETFs Trust Novo Nordi is an investment vehicle . It is currently trading at 21.79 USD.
Strategy: The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
Income: This appears to be an accumulating fund (dividends are reinvested) or focuses purely on capital growth.
No, it does not currently pay a dividend.
Precidian ETFs Trust Novo Nordi is classified as a ETF. You can compare it against its peer in the "Related Symbols" list.
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.07 USD
|
| Sept. 23, 2027 (estimated) | 0.0300 |
| June 23, 2027 (estimated) | 0.7667 |
| March 23, 2027 (estimated) | 0.2750 |
| ▸2026 |
1.56 USD
|
| Dec. 24, 2026 (estimated) | 0.4880 |
| Sept. 23, 2026 | 0.0300 |
| June 23, 2026 | 0.7667 |
| March 23, 2026 | 0.2750 |
| ▸2025 |
0.65 USD
|
| Dec. 24, 2025 | 0.4880 |
| Sept. 23, 2025 | 0.1657 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Precidian ETFs Trust Novo Nordi | Sep 23, 2026 | Paid | 0.03 USD |
| Precidian ETFs Trust Novo Nordi | Jun 23, 2026 | Paid | 0.76666 USD |
| Precidian ETFs Trust Novo Nordi | Mar 23, 2026 | Paid | 0.27495 USD |
| Precidian ETFs Trust Novo Nordi | Dec 24, 2025 | Paid | 0.48798 USD |
Community Discussion